A detailed history of Diversified Portfolios, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Diversified Portfolios, Inc. holds 5,629 shares of ABBV stock, worth $1.01 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
5,629
Previous 5,627 0.04%
Holding current value
$1.01 Million
Previous $965,000 15.13%
% of portfolio
0.13%
Previous 0.11%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$163.84 - $199.33 $327 - $398
2 Added 0.04%
5,629 $1.11 Million
Q2 2024

Jul 22, 2024

SELL
$154.79 - $180.76 $417,004 - $486,967
-2,694 Reduced 32.38%
5,627 $965,000
Q1 2024

May 07, 2024

SELL
$159.82 - $182.1 $58,494 - $66,648
-366 Reduced 4.21%
8,321 $1.52 Million
Q4 2023

Jan 30, 2024

SELL
$137.6 - $154.97 $2,339 - $2,634
-17 Reduced 0.2%
8,687 $1.35 Million
Q3 2023

Nov 02, 2023

BUY
$133.59 - $154.65 $2,271 - $2,629
17 Added 0.2%
8,704 $1.3 Million
Q2 2023

Aug 09, 2023

SELL
$132.51 - $164.9 $66,387 - $82,614
-501 Reduced 5.45%
8,687 $1.17 Million
Q4 2022

Jan 24, 2023

SELL
$138.31 - $165.87 $17,980 - $21,563
-130 Reduced 1.4%
9,188 $0
Q3 2022

Nov 07, 2022

SELL
$134.21 - $153.93 $213,528 - $244,902
-1,591 Reduced 14.58%
9,318 $1.25 Million
Q2 2022

Aug 09, 2022

SELL
$137.62 - $174.96 $68,810 - $87,480
-500 Reduced 4.38%
10,909 $1.67 Million
Q1 2022

May 12, 2022

SELL
$131.98 - $163.75 $29,299 - $36,352
-222 Reduced 1.91%
11,409 $1.85 Million
Q2 2021

Aug 03, 2021

BUY
$105.21 - $117.21 $472,603 - $526,507
4,492 Added 62.92%
11,631 $1.31 Million
Q1 2021

May 04, 2021

BUY
$102.3 - $112.62 $447,357 - $492,487
4,373 Added 158.1%
7,139 $773,000
Q3 2020

Oct 28, 2020

BUY
$85.91 - $100.83 $237,627 - $278,895
2,766 New
2,766 $242,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $317B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Diversified Portfolios, Inc. Portfolio

Follow Diversified Portfolios, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Diversified Portfolios, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Diversified Portfolios, Inc. with notifications on news.